GLSI - Greenwich LifeSciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 149.04M
Enterprise Value 137.13M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)12.76
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -17.06

Trading Information

Stock Price History

Beta (5Y Monthly) 3.49
52-Week Change 331.69%
S&P500 52-Week Change 33.90%
52 Week High 321.50
52 Week Low 36.82
50-Day Moving Average 311.73
200-Day Moving Average 312.49

Share Statistics

Avg Vol (3 month) 343.78k
Avg Vol (10 day) 320.32k
Shares Outstanding 512.85M
Implied Shares Outstanding 6N/A
Float 83.58M
% Held by Insiders 154.21%
% Held by Institutions 15.25%
Shares Short (May 14, 2023) 4242.03k
Short Ratio (May 14, 2023) 45.93
Short % of Float (May 14, 2023) 43.93%
Short % of Shares Outstanding (May 14, 2023) 41.88%
Shares Short (prior month Apr 13, 2023) 4340.01k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-32.72%
Return on Equity (ttm)-51.16%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-7.98M
Diluted EPS (ttm)-0.63
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.91M
Total Cash Per Share (mrq)0.93
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)50.56
Book Value Per Share (mrq)0.91

Cash Flow Statement

Operating Cash Flow (ttm)-5.81M
Levered Free Cash Flow (ttm)-3.01M